Share Value Dilution from the Exercise of Stock Acquisition Rights
First written in FY2016. 11 of 18 entries say "Materialised", first in FY2017-Q1. Latest entry: FY2021.
Silicon Studio Corp. moved to the "Worse" side of this theme in 2017, 4 years before the typical company in this theme (2021).
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
51 other companies' latest entry also says "Mitigated".
- FY2021MitigatedAnnual report
「This was due to the recognition of a gain on reversal of stock acquisition rights for which the exercise period had expired, amounting to ¥8 million as an extraordinary gain, a software impairment loss of ¥17 million as an extraordinary loss, and ¥20 million in income taxes, including deferred income taxes.」
A gain on reversal of ¥8 million was recognized for stock acquisition rights whose exercise period had expired, reducing future dilution exposure from their exercise. - FY2021-Q3MitigatedAnnual report
「Stock acquisition rights 9 — Gain on reversal of stock acquisition rights — 8」
Stock acquisition rights on the balance sheet decreased from ¥9 million at the end of the previous consolidated fiscal year to zero at the end of the third quarter, while the income statement recognized a gain on reversal of stock acquisition rights of ¥8 million. Future dilution exposure based on the balance of stock acquisition rights decreased. - FY2021-Q2MaterialisedAnnual report
「1 March 2021–31 May 2021 12,500 2,973,900 7 466 7 665 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 12,500 shares, increasing total shares issued to 2,973,900 and share capital and capital reserves by ¥7 million each. - FY2021-Q1MaterialisedAnnual report
「1 December 2020–28 February 2021 5,200 2,961,400 2 458 2 657 (Note) 1. Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights during the quarter resulted in the issuance of 5,200 shares, and share capital and capital reserves each increased by ¥2 million. An additional 12,500 stock acquisition rights were exercised by the filing date. - FY2020MitigatedAnnual report
「As of the end of November 2020, the total number of potential shares represented by stock acquisition rights was 164,300, equivalent to 5.56% of the total number of shares issued.」
The number of potential shares decreased from 172,300, or 5.84%, at the end of the previous fiscal year to 164,300, or 5.56%. In addition, 8,000 shares were issued during the year through the exercise of stock acquisition rights. - FY2020-Q3MaterialisedAnnual report
「1 June 2020–31 August 2020 (Note) 3,000 2,956,200 0 455 0 655 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights during the third quarter resulted in the issuance of 3,000 shares, increasing total shares issued to 2,956,200. Dilution continues to occur in practice. - FY2020-Q1MaterialisedAnnual report
「1 December 2019–29 February 2020 3,500 2,951,700 1 455 1 654 (Note) 1. Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights during the quarter resulted in the issuance of 3,500 shares, increasing total shares issued to 2,951,700. Dilution continues to occur in practice. - FY2019MaterialisedAnnual report
「As of the end of November 2019, the total number of potential shares represented by stock acquisition rights was 172,300, equivalent to 5.84% of the total number of shares issued.」
The exercise of stock acquisition rights during the year resulted in the issuance of 44,000 shares, and dilution continued to occur. Meanwhile, the number of remaining potential shares decreased from 222,700 at the end of the previous fiscal year to 172,300. - FY2019-Q2MaterialisedAnnual report
「1 March 2019–31 May 2019 (Note) 42,500 2,948,200 14 453 14 652 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights during the quarter resulted in the issuance of 42,500 shares, increasing total shares issued to 2,948,200. Dilution continues to occur in practice. - FY2019-Q1MaterialisedAnnual report
「1 December 2018– 28 February 2019 1,500 2,905,700 0 439 0 638 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights during the quarter resulted in the issuance of 1,500 shares, increasing total shares issued to 2,905,700. Dilution continues to occur in practice. - FY2018WorsenedAnnual report
「As of the end of November 2018, the total number of potential shares represented by stock acquisition rights was 222,700, equivalent to 7.67% of the total number of shares issued.」
The exercise of stock acquisition rights resulted in the issuance of 342,100 shares during the period, while 222,700 potential shares, equivalent to 7.67% of total shares issued, remain outstanding. - FY2018-Q3MaterialisedAnnual report
「1 June 2018–31 August 2018 9,100 2,902,700 1,543 439,177 1,543 638,427 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights during the third quarter resulted in the issuance of 9,100 shares, increasing total shares issued to 2,902,700. Dilution continues to occur in practice. - FY2018-Q2MaterialisedAnnual report
「27 March 2018 (Note 1) 50,000 2,613,600 49,950 196,414 49,950 395,664 24 April 2018 (Note 2) 140,000 2,753,600 123,830 320,244 123,830 519,494 25 May 2018 (Note 3) 140,000 2,893,600 117,390 437,634 117,390 636,884」
The exercise of Series 5 through Series 7 stock acquisition rights resulted in the issuance of a total of 330,000 shares, increasing total shares issued to 2,893,600. Dilution continues to occur in practice. - FY2018-Q1WorsenedAnnual report
「All exercises of the Series 5 stock acquisition rights issued by the Company on 26 March 2018 had been completed as of 27 March 2018.」
All 50,000 Series 5 stock acquisition rights were exercised, resulting in the delivery of 50,000 shares and the raising of ¥94.3 million. Series 6 through Series 10 stock acquisition rights were also issued, further increasing the number of potential shares in the future. - FY2017WorsenedAnnual report
「As of the end of November 2017, the number of potential shares represented by these stock acquisition rights was 71,200, equivalent to 2.78% of the total number of shares issued.」
Shares were also issued during the year through the exercise of stock acquisition rights, bringing the number of potential shares to 71,200, or 2.78%. In addition, as a subsequent event, the issuance of stock acquisition rights representing a total of 495,000 potential shares, from Series 5 through Series 10, was approved, increasing future dilution exposure. - FY2017-Q2MaterialisedAnnual report
「1 March 2017– 31 May 2017 (Note) 1 18,400 2,544,600 4,871 140,201 4,871 339,451 (Note) 1. Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 18,400 shares during the quarter, and dilution continued to occur. - FY2017-Q1MaterialisedAnnual report
「1 December 2016–28 February 2017 5,300 2,526,200 1,837 135,330 1,837 334,580 (Note) 1. Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 5,300 shares during the quarter, and dilution of potential shares actually occurred. - FY2016First statedAnnual report
「As of the end of November 2016, the number of potential shares represented by these stock acquisition rights was 112,400, equivalent to 4.46% of the total number of shares issued.」
The 112,400 potential shares represented by stock acquisition rights, equivalent to 4.46% of total shares issued, were disclosed quantitatively as a dilution risk.